No takes yet. Share an insight, caveat, or question.
Observational analysis found 58.5% eligible for next-day discharge after TAVR, indicating low complications.
Schouten et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: